Anti-Rheumatics Market Size, Share & Trends Analysis Report By Drug Class (Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Others), By Type (Prescription-Based Drugs, Over-the-Counter Drugs) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 09, 2026 | Author: Debashree B | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Anti-Rheumatics Market Size Analysis
    1. Introduction
    2. Anti-Rheumatics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Disease Modifying Anti-Rheumatic Drugs
      2. Nonsteroidal Anti-inflammatory Drugs
      3. Corticosteroids
      4. Uric Acid Drugs
      5. Others
    3. Anti-Rheumatics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Prescription-Based Drugs
      2. Over-the-Counter Drugs
  7. North America Anti-Rheumatics Market Size Analysis
    1. Introduction
    2. Anti-Rheumatics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Disease Modifying Anti-Rheumatic Drugs
      2. Nonsteroidal Anti-inflammatory Drugs
      3. Corticosteroids
      4. Uric Acid Drugs
      5. Others
    3. Anti-Rheumatics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Prescription-Based Drugs
      2. Over-the-Counter Drugs
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
  8. Europe Anti-Rheumatics Market Size Analysis
    1. Introduction
    2. Anti-Rheumatics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Disease Modifying Anti-Rheumatic Drugs
      2. Nonsteroidal Anti-inflammatory Drugs
      3. Corticosteroids
      4. Uric Acid Drugs
      5. Others
    3. Anti-Rheumatics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Prescription-Based Drugs
      2. Over-the-Counter Drugs
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    6. France
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
  9. APAC Anti-Rheumatics Market Size Analysis
    1. Introduction
    2. Anti-Rheumatics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Disease Modifying Anti-Rheumatic Drugs
      2. Nonsteroidal Anti-inflammatory Drugs
      3. Corticosteroids
      4. Uric Acid Drugs
      5. Others
    3. Anti-Rheumatics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Prescription-Based Drugs
      2. Over-the-Counter Drugs
    4. China
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    7. India
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    9. Singapore
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
  10. Middle East and Africa Anti-Rheumatics Market Size Analysis
    1. Introduction
    2. Anti-Rheumatics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Disease Modifying Anti-Rheumatic Drugs
      2. Nonsteroidal Anti-inflammatory Drugs
      3. Corticosteroids
      4. Uric Acid Drugs
      5. Others
    3. Anti-Rheumatics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Prescription-Based Drugs
      2. Over-the-Counter Drugs
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
  11. LATAM Anti-Rheumatics Market Size Analysis
    1. Introduction
    2. Anti-Rheumatics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Disease Modifying Anti-Rheumatic Drugs
      2. Nonsteroidal Anti-inflammatory Drugs
      3. Corticosteroids
      4. Uric Acid Drugs
      5. Others
    3. Anti-Rheumatics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Prescription-Based Drugs
      2. Over-the-Counter Drugs
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Disease Modifying Anti-Rheumatic Drugs
        2. Nonsteroidal Anti-inflammatory Drugs
        3. Corticosteroids
        4. Uric Acid Drugs
        5. Others
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Prescription-Based Drugs
        2. Over-the-Counter Drugs
  12. Competitive Landscape
    1. Anti-Rheumatics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. UCB S.A.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Pfizer Inc.
    3. AbbVie Inc.
    4. Eli Lilly and Company
    5. Johnson & Johnson
    6. Novartis AG
    7. Amgen Inc.
    8. F. HOFFMANN-LA ROCHE LTD.
    9. BRISTOL-MYERS SQUIBB COMPANY
    10. Merck & Co. Inc.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

We are featured on: